OMCL compared with ATRC: revenue, margins and what each company keeps, and the suppliers and customers both name

OMCLOmnicell, Inc.

Mkt capRevenueRevenue

ATRCAtriCure, Inc.

Mkt capRevenueRevenue

Compare

OMCLOmnicell, Inc.

ATRCAtriCure, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

OMCL

2 of 4at or beyond implied

Reportimpliedrealized× implied

Oct 29 '26thin chain±15.9%▲+2.59%×0.16

Q2 FY26±14.3%▼−10.36%×0.73

Q1 FY26±14.6%▲+20.94%×1.43

Feb 5 '26±14.9%▼−16.30%×1.09

ATRC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.5%▲+6.18%×0.40

Q1 FY26±12.9%▼−4.70%×0.36

= impliedOMCL realized, solidATRC realized, hatchedOne scale, both sides: full bar = 21%× = |realized| ÷ impliedSource: market data

Feb 18 '26

±14.3%

▼−2.15%

×0.15

Jan 12 '26±10.8%▼−9.21%×0.85

OMCLOmnicell, Inc.

36.69▼−0.52%· post 36.69

Mkt cap$1.7BRevenue$312MQ2 FY26Revenue$1.2BFY25

ATRCAtriCure, Inc.

61.22▼−2.02%· post 61.21

ClosedOct 30 '26

Mkt cap$3.1BRevenue$154MQ2 FY26Revenue$535MFY25

Compare

ClosedOct 30 '26

OMCLOmnicell, Inc.

ATRCAtriCure, Inc.

36.69▼−0.52%post 36.69

Price

61.22▼−2.02%post 61.21

$1.7B

Mkt cap

$3.1B

Q2 FY26$312M

Revenue

$154MQ2 FY26

FY25$1.2B

Revenue

$535MFY25

OMCL36.69▼−0.52%vsATRC61.22▼−2.02%ClosedOct 30 '26